Clinical Trial
Biphenabid (Probucol): a new hypocholesterolemic agent
- PMID: 5000716
Item in Clipboard
Clinical Trial
Biphenabid (Probucol): a new hypocholesterolemic agent
Curr Ther Res Clin Exp.
1971 Nov.
No abstract available
Similar articles
-
Probucol, a new cholesterol lowering drug.J Med. 1975;6(5-6):305-15. J Med. 1975. PMID: 768396 Clinical Trial.
-
[Clinical assessment of probucol and its therapeutical effect on hypercholesterolaemia (author's transl)].Cas Lek Cesk. 1981 Jul 9;120(27):832-5. Cas Lek Cesk. 1981. PMID: 7261004 Czech. No abstract available.
-
[Action of the new hypocholesteremic agent DH-581 (dithiobisphenol) in humans].Prensa Med Argent. 1971 Oct 8;58(32):1587-94. Prensa Med Argent. 1971. PMID: 4943247 Clinical Trial. Spanish. No abstract available.
-
[Pharmacology of probucol. I].Clin Ter. 1984 Mar 15;108(5):367-88. Clin Ter. 1984. PMID: 6232074 Review. Italian. No abstract available.
-
Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.Circulation. 2003 Jul 1;107(25):3124-8. doi: 10.1161/01.CIR.0000072345.98581.24. Circulation. 2003. PMID: 12835406 Review. No abstract available.
Cited by
-
Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia.Drugs. 1978 Jun;15(6):409-28. doi: 10.2165/00003495-197815060-00001. Drugs. 1978. PMID: 350557 Review. No abstract available.